ArticleNeoplasia (New York, N.Y.)2005

Vascular targeting in pancreatic cancer: the novel tubulin-binding agent ZD6126 reveals antitumor activity in primary and metastatic tumor models.

Axel Kleespies et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.